PPARδ Signaling Regulates Colorectal Cancer

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|21|21|2956-2959

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.21, Iss.21, 2015-06, pp. : 2956-2959

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anti-metastatic Treatment in Colorectal Cancer: Targeting Signaling Pathways

By  

Current Pharmaceutical Design, Vol. 19, Iss. 5, 2013-02 ,pp. : 841-863

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the Most Upstream Site of Wnt Signaling Pathway Provides a Strategic Advantage for Therapy in Colorectal Cancer

By  

Current Drug Targets, Vol. 9, Iss. 7, 2008-07 ,pp. : 548-557

Bentham Science Publishers

Access to resources Recommend Favorite

AP-1 and colorectal cancer

By Ashida Reiko  

Inflammopharmacology, Vol. 13, Iss. 1-3, 2005-08 ,pp. : 113-125

VSP

Access to resources Recommend Favorite

Role of oxaliplatin in colorectal cancer

By  

Inpharma, Vol. 1, Iss. 1227, 2000-01 ,pp. : 3-4

Adis International

Access to resources Recommend Favorite

Pharmacogenetics of colorectal cancer

By Marsh Sharon  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 15, 2005-12 ,pp. : 2607-2616

Informa Healthcare

Access to resources Recommend Favorite